CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,101,676 | -14.4% | 3,291,950 | +2.7% | 0.00% | – |
| Q2 2023 | $3,623,478 | -11.0% | 3,206,618 | 0.0% | 0.00% | – |
| Q1 2023 | $4,072,405 | +118.1% | 3,206,618 | +29.9% | 0.00% | – |
| Q4 2022 | $1,867,418 | +20.5% | 2,469,150 | +0.0% | 0.00% | – |
| Q3 2022 | $1,550,000 | +28.8% | 2,467,933 | +0.3% | 0.00% | – |
| Q2 2022 | $1,203,000 | -41.3% | 2,461,633 | 0.0% | 0.00% | – |
| Q1 2022 | $2,050,000 | -34.8% | 2,461,633 | -0.6% | 0.00% | – |
| Q4 2021 | $3,146,000 | -29.4% | 2,476,970 | +24.4% | 0.00% | – |
| Q3 2021 | $4,458,000 | +11.1% | 1,990,369 | +0.2% | 0.00% | – |
| Q2 2021 | $4,013,000 | -29.5% | 1,986,440 | -7.2% | 0.00% | – |
| Q1 2021 | $5,695,000 | +49.8% | 2,141,127 | +12.7% | 0.00% | – |
| Q4 2020 | $3,801,000 | -49.2% | 1,900,165 | -27.7% | 0.00% | – |
| Q3 2020 | $7,489,000 | +20.9% | 2,627,401 | +56.6% | 0.00% | – |
| Q2 2020 | $6,192,000 | +97.6% | 1,677,947 | +32.8% | 0.00% | – |
| Q1 2020 | $3,133,000 | +20.1% | 1,263,279 | +86.0% | 0.00% | – |
| Q4 2019 | $2,608,000 | +92.5% | 679,085 | 0.0% | 0.00% | – |
| Q3 2019 | $1,355,000 | +12.4% | 679,085 | -5.4% | 0.00% | – |
| Q2 2019 | $1,206,000 | -52.9% | 717,631 | -25.7% | 0.00% | – |
| Q1 2019 | $2,561,000 | +25.9% | 966,340 | +11.6% | 0.00% | – |
| Q4 2018 | $2,034,000 | -30.0% | 865,734 | +31.1% | 0.00% | – |
| Q3 2018 | $2,906,000 | -2.7% | 660,485 | +15.0% | 0.00% | – |
| Q2 2018 | $2,987,000 | +32.2% | 574,506 | +1.7% | 0.00% | – |
| Q1 2018 | $2,260,000 | -41.2% | 565,106 | -0.1% | 0.00% | – |
| Q4 2017 | $3,846,000 | -14.1% | 565,665 | +2.3% | 0.00% | – |
| Q3 2017 | $4,478,000 | +98.7% | 552,778 | +83.9% | 0.00% | – |
| Q2 2017 | $2,254,000 | -15.8% | 300,547 | -12.4% | 0.00% | – |
| Q1 2017 | $2,677,000 | -22.6% | 343,184 | +3.2% | 0.00% | – |
| Q4 2016 | $3,457,000 | +62.7% | 332,472 | +79.2% | 0.00% | – |
| Q3 2016 | $2,125,000 | +19.7% | 185,575 | +7.7% | 0.00% | – |
| Q2 2016 | $1,776,000 | -13.8% | 172,233 | +6.2% | 0.00% | – |
| Q1 2016 | $2,061,000 | -10.7% | 162,252 | +20.6% | 0.00% | – |
| Q4 2015 | $2,309,000 | -98.6% | 134,541 | -97.1% | 0.00% | -100.0% |
| Q3 2015 | $166,079,000 | +13625.5% | 4,677,924 | +5323.9% | 0.01% | – |
| Q2 2015 | $1,210,000 | – | 86,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |